object value efficacy tower sorafenib combine cryoablat treat unrest hepatocellular carcinoma cc method patient advance receive dose mg twice daily week cycle day tumor response median overall survive time radiology progress call toxic value result seventyeight involve studi age year rang eastern cooper oncology group eco perform status score nine barcelona clinic liver cancer oclc stage twentyfour b c five achieve partial response stable disease http enroll month o concur demons good accept 